비교리스트

 카트 문의
시장보고서
상품코드
1454120

미오글로빈 시장 : 제품별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Myoglobin Market, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 289 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

미오글로빈 시장 규모는 2023년 9,845만 달러로 평가되었고, 2024년부터 2032년까지 연평균 4.1% 성장할 것으로 예상됩니다.

미오글로빈 시장 - 시장 역학

CVD 유병률 증가가 시장 성장을 주도하고 있습니다.

미오글로빈 시장의 성장을 가속하는 중요한 요인 중 하나는 심혈관 질환(CVDs)의 발병률 증가입니다. 심혈관 질환은 심부전, 심근경색증 등 인구의 대다수에게 영향을 미치는 질환입니다. 이는 전 세계적인 건강 문제입니다. 미국심부전학회의 조사에 따르면, 2030년까지 심부전으로 고통받는 미국인의 수는 650만 명에서 800만 명 이상으로 증가할 것으로 예상됩니다. 골격근과 심근에 존재하는 필수 단백질 미오글로빈은 심장 질환을 발견하고 추적하는 데 필수적이며, CVD의 빈도가 증가함에 따라 심장 건강을 평가하고 이상을 식별하기 위해 더 효과적이고 빠른 진단 방법이 요구되고 있습니다. 미오글로빈은 심근 질환의 조기 발견에 도움이 되는 중요한 바이오마커로, 신속한 치료와 환자의 예후를 개선할 수 있습니다.

미오글로빈 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 4.1%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

제품 세분화에 따라 인간 미오글로빈 부문은 예측 기간 동안 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.

용도별로는 예측 기간 동안 병원 부문이 시장을 장악할 것으로 예상됩니다.

지역별로는 북미가 예측 기간 동안 시장을 독점할 것으로 예상됩니다.

미오글로빈 시장 - 세분화 분석 :

세계 미오글로빈 시장은 제품, 용도 및 지역에 따라 세분화됩니다.

제품에 따라 미오글로빈 시장은 인간 미오글로빈과 동물용 미오글로빈으로 나뉩니다. 인간 미오글로빈 부문은 예측 기간 동안 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 인간 미오글로빈은 임상 및 의학 연구에서 중요한 역할을 하고 있습니다. 헴 단백질인 미오글로빈은 주로 근육 조직에 존재하며 일부 질병, 특히 심장 질환 분야에서 필수적인 바이오마커입니다.

용도에 따라 세계 미오글로빈 시장은 병원, 연구기관 및 기타로 분류됩니다. 예측 기간 동안 병원 부문이 시장을 지배할 것으로 예상됩니다. 병원은 환자 치료의 중심지이며, 신속하고 정확한 진단의 필요성이 증가하고 있습니다. 미오글로빈 검사 및 분석은 심장 질환을 신속하게 감지하고 심근경색 및 심장마비와 같은 심장 관련 문제를 조기에 발견하는 데 필수적입니다.

미오글로빈 시장 - 지리적 통찰력

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 예측 기간 동안 북미가 시장을 지배할 것으로 예상됩니다. 이 지역에서는 심장 관련 질환의 유병률이 증가하고 심혈관 건강에 대한 인식이 높아짐에 따라 미오글로빈 기반 진단에 대한 수요가 증가하고 있습니다. 또한, 북미의 발전된 의료 시스템과 연구 커뮤니티는 미오글로빈 기반 진단 도구의 발전과 사용을 지원하는 분위기를 조성하고 있습니다. 미오글로빈 분석에 대한 수요는 분석에 대한 접근성과 정확성을 향상시키는 현장 검사 등 의료 기술의 지속적인 개선으로 인해 더욱 증가하고 있습니다. 북미가 미오글로빈의 강력한 시장인 이유는 이 지역이 혁신적인 의료 솔루션에 전념하고 환자 결과를 개선하는 데 중점을 두고 있기 때문입니다. 의료 산업에서 연구와 혁신이 계속 활발히 진행되는 한 지속적인 성장 잠재력이 있습니다.

미오글로빈 시장 - 경쟁 구도:

시장에 진출한 주요 기업으로는 Randox Laboratories, Beckman Coulter, Abbott Diagnostics, Siemens Healthcare Diagnostics, Boditech Med, Biomerieux, Roche Diagnostics Corp, Ortho-Clinical Diagnostics, Singulex, Alere 등이 있습니다. 이들 기업은 제품 출시, 인수, 제휴 등 다양한 전략을 통해 업계에서 주요 시장 점유율을 확보하기 위해 노력하고 있습니다.

목차

제1장 미오글로빈 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 미오글로빈 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 미오글로빈 산업 조사

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 미오글로빈 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 미오글로빈 시장 구도

  • 미오글로빈 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 미오글로빈 시장 - 제품별

  • 개요
    • 제품별 부문 점유율 분석
    • 인간용 미오글로빈
    • 동물용 미오글로빈

제8장 미오글로빈 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 병원
    • 연구기관
    • 기타

제9장 미오글로빈 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제10장 주요 벤더 분석 미오글로빈 산업

  • 경쟁 대시보드
  • 기업 개요
    • Randox Laboratories
    • Beckman Coulter
    • Abbott Diagnostics
    • Siemens Healthcare Diagnostics
    • Boditech Med
    • Biomerieux
    • Roche Diagnostics Corp
    • Ortho-Clinical Diagnostics
    • Singulex
    • Alere

제11장 애널리스트의 전방위 전망

LSH 24.04.30

REPORT HIGHLIGHT

Myoglobin Market size was valued at USD 98.45 Million in 2023, expanding at a CAGR of 4.1% from 2024 to 2032.

A small, globular protein called myoglobin is present in the heart and skeletal muscles of animals. It was the first protein whose 3D structure was fully understood using X-ray crystallography. This protein's primary job is to store and supply oxygen to muscles that are exercising hard when blood oxygen delivery is momentarily inadequate. It helps diving mammals like whales and seals stay underwater for extended periods of time because it is abundant in their muscles. The molecular structures of hemoglobin and myoglobin, the proteins that bind oxygen to blood cells, are identical because heme, a crucial component, is present. Heme facilitates the binding of oxygen to both hemoglobin and myoglobin.

Myoglobin Market- Market Dynamics

Rising prevalence of CVDs drives market growth

One significant factor propelling the myoglobin market's rise is the rising incidence of cardiovascular diseases (CVDs). Cardiovascular disorders, which impact a large percentage of the population, include heart failure and myocardial infarctions. They are a major worldwide health problem. As to the research from the Heart Failure Society of America, it is anticipated that by 2030, the number of Americans suffering from heart failure would rise from 6.5 million to over 8 million. The essential protein myoglobin, which is present in both skeletal and cardiac muscles, is essential for the detection and tracking of cardiac disorders. More effective and fast diagnostic procedures are required to assess heart health and identify abnormalities due to the rising frequency of CVDs. Myoglobin is a vital biomarker that can help identify myocardial injury early on, allowing for prompt medical attention and possibly better patient outcomes.

Myoglobin Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.1% over the forecast period (2024-2032)

Based on product segmentation, the Human Myoglobin segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the hospitals segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Myoglobin Market- Segmentation Analysis:

The Global Myoglobin Market is segmented based on Product, Application and Region.

Based on the product, the Myoglobin market is bifurcated into Human Myoglobin and Animal Myoglobin. The Human Myoglobin segment is expected to capture the largest revenue share over the projected period. In clinical settings and medical research, the role of human myoglobin has grown. Hemoprotein myoglobin, which is mostly present in muscle tissues, is an essential biomarker for several medical diseases, particularly in the field of cardiology.

Based on the application, the global Myoglobin market is segmented into Hospital, Research Institutes and Others. The hospitals segment is expected to dominate the market over the projected period. The main centers for patient care are hospitals, and there is a growing need for rapid and precise diagnoses. Myoglobin tests and assays are essential for quickly detecting cardiac injury and supporting the early detection of heart-related problems such myocardial infarctions or heart attacks.

Myoglobin Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The need for myoglobin-based diagnostics has increased due to the region's increased heart-related illness prevalence and growing awareness of cardiovascular health. Furthermore, the developed healthcare system and research community in North America offer a supportive atmosphere for the advancement and use of myoglobin-based diagnostic tools. The need for myoglobin assays is also being further fueled by continuous improvements in medical technology, such as point-of-care testing, which increases the assays' accessibility and accuracy. North America is a strong market for myoglobin because to the region's dedication to innovative healthcare solutions and emphasis on improving patient outcomes. As long as research and innovation in the healthcare industry continue to flourish, there is potential for continued growth.

Myoglobin Market- Competitive Landscape:

The key players operating in the market are Randox Laboratories, Beckman Coulter, Abbott Diagnostics, Siemens Healthcare Diagnostics, Boditech Med, Biomerieux, Roche Diagnostics Corp, Ortho-Clinical Diagnostics, Singulex and Alere. These players adopted various strategies to gain major market share in the industry including product launch, acquisition, collaboration and others.

Recent Developments:

In December 2022, Precision fermentation has been used by Argentine business Ergo Bioscience to create plant-based substitutes for animal components. Casein and myoglobin are examples of this. Ergo Bioscience teamed up with Aethera Biotech in November 2022 to expand its precision fermentation bioprocesses. The collaboration will be centered on enhancing the biotech procedures used to produce casein and myoglobin without using animals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MYOGLOBIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Randox Laboratories

Beckman Coulter

Abbott Diagnostics

Siemens Healthcare Diagnostics

Boditech Med

Biomerieux

Roche Diagnostics Corp

Ortho-Clinical Diagnostics

Singulex

Alere

GLOBAL MYOGLOBIN MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Human Myoglobin
  • Animal Myoglobin

GLOBAL MYOGLOBIN MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Research Institutes
  • Others

GLOBAL MYOGLOBIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Myoglobin Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Myoglobin Market Snippet by Product
    • 2.1.2.Myoglobin Market Snippet by Application
    • 2.1.3.Myoglobin Market Snippet by Country
    • 2.1.4.Myoglobin Market Snippet by Region
  • 2.2.Competitive Insights

3.Myoglobin Key Market Trends

  • 3.1.Myoglobin Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Myoglobin Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Myoglobin Market Opportunities
  • 3.4.Myoglobin Market Future Trends

4.Myoglobin Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Myoglobin Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Myoglobin Market Landscape

  • 6.1.Myoglobin Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Myoglobin Market - By Product

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2.Human Myoglobin
    • 7.1.3.Animal Myoglobin

8.Myoglobin Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Hospital
    • 8.1.3.Research Institutes
    • 8.1.4.Others

9.Myoglobin Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Myoglobin Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Myoglobin Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Myoglobin Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Myoglobin Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Myoglobin Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Myoglobin Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Randox Laboratories
    • 10.2.2.Beckman Coulter
    • 10.2.3.Abbott Diagnostics
    • 10.2.4.Siemens Healthcare Diagnostics
    • 10.2.5.Boditech Med
    • 10.2.6.Biomerieux
    • 10.2.7.Roche Diagnostics Corp
    • 10.2.8.Ortho-Clinical Diagnostics
    • 10.2.9.Singulex
    • 10.2.10.Alere

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제